Den anbefalede dosis bør administreres som intravenøs infusion, selvom opløsningen er blevet administreret via et centralt venekateter i igangværende kliniske forsøg.
The recommended dosage should be administered by intravenous infusion although it has been administered via a central venous catheter in ongoing clinical trials.